Towards the personalized medicine for metastatic renal cell cancer

迈向转移性肾细胞癌的个体化医疗

• 批准号: 16K11035
• 负责人: YUASA Takeshi
• 金额: $ 3万
• 依托单位: Japanese Foundation for Cancer Research
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 2016
• 资助国家: 日本
• 起止时间: 2016-04-01 至 2019-03-31
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K11035/
• 关键词: 腎癌; 分子標的治療; 予後因子; 血管新生阻害剤; バイオマーカー; 糖枯渇; HIF-2; ミトコンドリア機能; VHL; 治療耐性; 次世代シーケンサー; 遺伝子発現; 遺伝子変異

项目成果

Clinical Value of F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. . .

F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在上尿路尿路上皮癌中的临床价值：对转移检测和患者管理的影响。

• DOI: 10.1159/000381269
• 发表时间: 2016
• 影响因子: 1.6
• 作者: Tanaka H; Yoshida S; Komai Y; Sakai Y; Urakami S; Yuasa T; Yamamoto S; Masuda H; Koizumi M; Kohno A; Fukui I; Yonese J; Fujii Y; Kihara K.
• 通讯作者: Kihara K.

Preliminary Kidney Parenchymal Ligation Using Endoloop Ligatures-A Simple Method to Achieve a Trifecta in Laparoscopic Partial Nephrectomy Without Hilar Clamping for Polar Complex Tumors.

使用内环结扎线进行初步肾实质结扎——一种在腹腔镜肾部分切除术中实现三连胜的简单方法，无需钳夹极地复杂肿瘤。

• DOI: 10.1016/j.urology.2018.08.023
• 发表时间: 2018
• 作者: Komai Y; Gotohda N; Matsubara N; Takeda H; Yuasa T; Inoue M; Yamamoto S; Yonese J.
• 通讯作者: Yonese J.

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

体重指数和转移性肾细胞癌：临床和生物学相关性。

• 发表时间: 2018
• 作者: Albiges L; Hakimi AA; Xie W; McKay RR; Simantov R; Lin X; Lee JL; Rini BI; Srinivas S; Bjarnason GA; Ernst S; Wood LA; Vaishamayan UN; Rha SY; Agarwal N; Yuasa T; Pal SK; Bamias A; Zabor EC; Sk;erup AJ; Furberg H; Fay AP; de Velasco G; Preston MA; Wilso
• 通讯作者: Wilso

A case of gastric metastasis from renal cell cancer during the sequential targeted therapy.

序贯靶向治疗肾细胞癌胃转移一例。

• DOI: 10.1007/s13691-017-0286-x
• 发表时间: 2017
• 作者: Uehara S; Yuasa T; Fujisaki J; Fujii Y; Yamamoto S; Masuda H; Fukui I; Yonese J.
• 通讯作者: Yonese J.

Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors.

C反应蛋白的早期反应作为酪氨酸激酶抑制剂治疗的转移性肾细胞癌患者生存的预测因子。

• DOI: 10.1007/s10147-017-1166-2
• 发表时间: 2017
• 作者: Yasuda Y; Saito K; Yuasa T; Uehara S; Kawamura N; Yokoyama M; Ishioka J; Matsuoka Y; Yamamoto S; Okuno T; Yonese J; Kihara K; Fujii Y.
• 通讯作者: Fujii Y.